Horien Biochemical Technology Co (ROCO:7814) Days Payable: 21.86 (As of Dec. 2025) — 25% Below Median


ROCO:7814 Horien Biochemical Technology Co Ltd ROCO:7814
21 GF Score
Price NT$36.15
! 5 Warning Signs
View Full Analysis

What is Horien Biochemical Technology Co Days Payable?

Horien Biochemical Technology Co ROCO:7814 21 Days Payable is 21.86 as of Dec. 2025, which is 25% below its 10-year median of 29.11. GuruFocus rates ROCO:7814 with a GF Score™ of 21/100. The stock has 5 warning signs investors should review. Among 701 Biotechnology companies, Horien Biochemical Technology Co ranks worse than 66.48% on this metric.

Horien Biochemical Technology Co's average Accounts Payable for the three months ended in Dec. 2025 was NT$1.77 Mil. Horien Biochemical Technology Co's Cost of Goods Sold for the three months ended in Dec. 2025 was NT$7.40 Mil. Hence, Horien Biochemical Technology Co's Days Payable for the three months ended in Dec. 2025 was 21.86.

The historical rank and industry rank for Horien Biochemical Technology Co's Days Payable or its related term are showing as below:

ROCO:7814' s Days Payable Range Over the Past 10 Years
Min: 25.55   Med: 29.11   Max: 53.07
Current: 53.07

During the past 4 years, Horien Biochemical Technology Co's highest Days Payable was 53.07. The lowest was 25.55. And the median was 29.11.

ROCO:7814's Days Payable is ranked worse than
66.48% of 701 companies
in the Biotechnology industry
Industry Median: 112.84 vs ROCO:7814: 53.07

Horien Biochemical Technology Co's Days Payable declined from Sep. 2024 (42.55) to Dec. 2025 (21.86). It may suggest that Horien Biochemical Technology Co accelerated paying its suppliers.

Horien Biochemical Technology Co Days Payable Related Terms

Horien Biochemical Technology Co Days Payable Historical Data

* Premium members only.

The historical data trend for Horien Biochemical Technology Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Horien Biochemical Technology Co Days Payable Chart

Horien Biochemical Technology Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Days Payable
36.56 25.55 25.90 32.31

Horien Biochemical Technology Co Quarterly Data
Dec22 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Days Payable Get a 7-Day Free Trial 42.55 29.35 0.00 26.34 21.86

ROCO:7814 vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Horien Biochemical Technology Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Horien Biochemical Technology Co Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Horien Biochemical Technology Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Horien Biochemical Technology Co's Days Payable falls into.


ROCO:7814
21GF Score
Horien Biochemical Technology Co Ltd ROCO:7814
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Horien Biochemical Technology Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Horien Biochemical Technology Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (2.416 + 1.92) / 2 ) / 24.492*365
=2.168 / 24.492*365
=32.31

Horien Biochemical Technology Co's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Sep. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (1.628 + 1.92) / 2 ) / 7.404*365 / 4
=1.774 / 7.404*365 / 4
=21.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 21.86 mean?
Horien Biochemical Technology Co (ROCO:7814) has a Days Payable of 21.86 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Horien Biochemical Technology Co and its competitors. This is 25% below median its historical median of 29.11. Over the past decade, Horien Biochemical Technology Co's Days Payable has ranged from 25.55 to 53.07. According to the industry distribution chart, Horien Biochemical Technology Co ranks #466 out of 701 companies in the Biotechnology industry, placing it in the top 66.5%.
Is Horien Biochemical Technology Co's Days Payable too high?
Horien Biochemical Technology Co's current Days Payable of 21.86 is 25% below median its 10-year median of 29.11. Over the past 10 years, this metric has ranged from a low of 25.55 to a high of 53.07. The Biotechnology industry median Days Payable is 112.84. Horien Biochemical Technology Co's value of 21.86 is 80.6% below this industry median. Based on the distribution chart, Horien Biochemical Technology Co ranks #466 out of 701 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Horien Biochemical Technology Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Horien Biochemical Technology Co's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Horien Biochemical Technology Co ranks #466 out of 701 companies for Days Payable. This places Horien Biochemical Technology Co in the lower half of its industry. The industry median Days Payable is 112.84. Horien Biochemical Technology Co's value of 21.86 is 80.6% below this benchmark. Historically, Horien Biochemical Technology Co's own Days Payable has ranged from 25.55 to 53.07 over the past decade. While the company's 10-year median is 29.11 vs. the industry median of 112.84, Horien Biochemical Technology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Horien Biochemical Technology Co's current Days Payable of 21.86 is 80.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Horien Biochemical Technology Co and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Horien Biochemical Technology Co's current Days Payable is 21.86, which is 25% below median its own 10-year median of 29.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Horien Biochemical Technology Co stock overvalued right now?
Horien Biochemical Technology Co (ROCO:7814) has a current Days Payable of 21.86. The current Days Payable is 21.86, which is 25% below median its 10-year median of 29.11 and 80.6% below the Biotechnology industry median of 112.84. Horien Biochemical Technology Co's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Horien Biochemical Technology Co (ROCO:7814), the current Days Payable is 21.86 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Horien Biochemical Technology Co Business Description

Address Gongyecyu 38th Road, 7F-5 & 6, NO. 210, Situn District, Siehe Village, Taichung, TWN, 40768
Horien Biochemical Technology Co Ltd is engaged in the research and development of cosmetic raw materials and medical devices and facilities. The products of the company include Gen-Nusis, skin repairment ingredients, PeptioMax, the latest cosmetic raw material, Lifkin, and other substitutes used in dentistry and general surgery.
21GF Score

Get the complete analysis for ROCO:7814

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$36.15
Price